Followers | 251 |
Posts | 50346 |
Boards Moderated | 41 |
Alias Born | 08/29/2007 |
Sunday, April 28, 2024 9:33:12 AM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent NMRA News
- Neumora Therapeutics Announces Initiation of Phase 2 Study of Navacaprant in Bipolar Depression • GlobeNewswire Inc. • 05/14/2024 11:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2024 08:01:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 11:15:12 AM
- Neumora Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/07/2024 11:00:00 AM
- Neumora Therapeutics to Participate in Upcoming Conferences in May • GlobeNewswire Inc. • 05/06/2024 11:00:00 AM
- Neumora Therapeutics Announces Clinical Hold of Phase 1 NMRA-266 Study • GlobeNewswire Inc. • 04/15/2024 10:30:00 AM
- Neumora Therapeutics to Participate at Stifel 2024 Virtual CNS Days • GlobeNewswire Inc. • 03/13/2024 11:00:00 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/07/2024 09:34:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 12:08:00 PM
- Neumora Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 03/07/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 09:21:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 09:19:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 09:14:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 09:13:03 PM
- Neumora Therapeutics Appoints Kaya Pai Panandiker as Chief Commercial Officer • GlobeNewswire Inc. • 01/22/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 01:32:58 PM
- Neumora Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/02/2024 12:00:00 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 12/15/2023 10:06:57 PM
- Neumora Therapeutics Appoints Jason Duncan as Chief Legal Officer • GlobeNewswire Inc. • 12/12/2023 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 09:21:29 PM
- Neumora Therapeutics Announces NMRA-266 IND Clearance and Initiation of Phase 1 Clinical Study • GlobeNewswire Inc. • 11/27/2023 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/01/2023 08:05:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2023 08:01:34 PM
- Neumora Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 11/01/2023 11:00:00 AM
- Neumora Therapeutics to Participate in Upcoming Conferences in November • GlobeNewswire Inc. • 10/30/2023 11:00:00 AM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM